NASDAQ: CAPR · Biotechnology
Over the past week, Capricor Therapeutics (CAPR) drew 14 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 13% bullish but is deeply split: News runs 40% bullish while X sits at just 0%. Wall Street is more constructive, with 2 of 9 analysts rating CAPR a buy.
There is little buzz around CAPR this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 22% buy share sits next to a crowd that ranges from X at 0% to News at 40%. No other tracker puts the two side by side.
Across 9 analysts the consensus is a Hold: 2 buy calls against 0 sell, with an average 12-month price target of $27.00.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is cooling and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 9 points above the crowd average of 13%, the professionals are more constructive than retail. The split is inside the crowd: News reads 40% bullish while X sits at 0%, a 40-point spread that single-source trackers miss.
Weekly price context: this Alpha Vantage chart keeps its own dated range; the sentiment metrics elsewhere on this page may be newer. Over the 30-day window, Capricor Therapeutics (CAPR) buzz held subdued around 12.8 while the price drifted down 12.8% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 3.3M shares. Updated Sep 26, 2026. Over the last 7 trading days, CAPR lost 11.3%. Buzz activity in the recent week averaged 27.1 and was variable, swinging between 12.8 and 50.4. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 9 of the 20 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for CAPR and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live CAPR sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 28, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Hold (2 / 7 / 0) |
| Crowd bullish (7d) | 13% |
| Avg price target | $27.00 |
| Most bullish source | News, 40% |
| Most bearish source | X, 0% |
| Sentiment spread | 40 pts |
| Mentions (7d) | 14 |
| Market cap | $498.3M |
| P/E · Forward P/E | n/a · 78.7 |
| EPS · Beta | -$2.42 · 0.7 |
| Revenue (TTM) | $11.1M · 0% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Capricor Therapeutics (CAPR) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 13% bullish across 3 active sources. Those sources contribute 14 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Capricor Therapeutics (CAPR) is fairly quiet with 3 mentions over the last 7 days; the 30-day context spans 6 tracked subreddits. The 7-day tone is 0% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bearish on Capricor Therapeutics (CAPR), averaging 13% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 40% bullish and X at 0%, a 40-point spread. On the professional side, 2 of 9 analysts rate CAPR a buy.
Of the 9 analysts covering Capricor Therapeutics (CAPR), 2 rate it a buy, 7 a hold and 0 a sell, for a hold consensus. The average price target is $27.00. That puts the street ahead of the crowd, which averages 13% bullish.
Capricor Therapeutics (CAPR)'s cross-source average is bearish at 13% bullish. All 3 tracked sources lean bearish. X reads 0% bullish, News reads 40% bullish and reddit coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Capricor Therapeutics (CAPR) at 13% bullish. All 3 tracked sources lean bearish. The most bearish reading is reddit at 0% bullish. 3-day activity momentum is falling across News. The sell signal carries 93/100 conviction.
News is the dominant discussion channel with 10 mentions (71% of total volume). Reddit contributes 3 mentions and X contributes 1 mention. The cross-source average is bearish at 13% bullish. All 3 tracked sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. CAPR's sell signal at 93/100 conviction reflects a bearish cross-source average at 13% bullish. All 3 tracked sources lean bearish. It is a research shortcut, not financial advice.
The CAPR sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key